| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.133.568 |
| Chemical and physical data | |
| Formula | C15H22N4O3 |
| Molar mass | 306.366 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Propentofylline (HWA 285) is axanthine derivative drug with purportedneuroprotective effects.
It is aphosphodiesterase inhibitor,[1] and also acts as anadenosine reuptake inhibitor.[1][2][3]
Propentofylline was studied as a possible treatment forAlzheimer's disease andmulti-infarct dementia,[1][4] and has been studied, to a lesser extent, as a possible adjunct in the treatment ofischemic stroke, due to itsvasodilating properties.[5][6]
Propentofylline is in use as a veterinary medicine in older dogs.[7]